CLINICAL_TRIALS
safety_alert
· 2014-01-14
Clinical Trial Update: Kidney Damage In Patients With Severe Fall In eGFR [Phase 4]
Summary
Phase 4 trial evaluating kidney damage in patients with severe eGFR decline was terminated; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Bracco Diagnostics, Inc | Conditions: Coronary Artery Stenosis | Phase 4 | Status: TERMINATED | Results posted: 2014-01-14